10x Genomics TXG 深 沪
已收盘 10-31 16:00:00 美东时间
13.64
+1.200
+9.65%
华盛通- 最 高13.85
- 今 开12.56
- 成交量 261.42万股
- 最 低 12.44
- 昨 收 12.44
- 总市值 16.91亿
- 52周最高 17.25
- 市盈率 静 --
- 换手率 2.11%
- 52周最低 6.78
- 委 比 71.07%
- 总股本 1.24亿
- 历史最高 208.99
- 量 比 1.16
- 振 幅 11.33%
- 历史最低 6.78
- 每 手 1
- 风险率 2.45%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多10x Genomics Rolls Out Flex Assay To Offer Cost-Effective Single Cell Analysis
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced the launch of the next generation of its high-performance Flex assay, featuring automation-compatible plate-based
10-29 21:03
Analyst Expectations For 10x Genomics's Future
Providing a diverse range of perspectives from bullish to bearish, 4 analysts h...
10-24 03:01
Scotiabank Maintains Sector Outperform on Torex Gold Resources, Raises Price Target to C$72
Scotiabank analyst Eric Winmill maintains Torex Gold Resources (TSX:TXG) with a Sector Outperform and raises the price target from C$58 to C$72.
10-23 23:29
Cathie Wood Warns Wall Street Is Missing AI's Biggest Opportunity In Healthcare, Calling It 'Sleeper' Investment Poised For Massive Returns
Cathie Wood, CEO of Ark Invest, believes healthcare is the most profound application of AI and Wall Street is overlooking its potential.
10-15 18:17
Torex Gold’s Drilling Success at ELG Underground Signals Extended Mine Life
Torex Gold Resources ( ($TSE:TXG) ) has issued an announcement. Torex Gold Reso...
10-06 19:51
TX Group Launches Share Buyback Program
TX Group AG ( ($CH:TXGN) ) just unveiled an announcement. TX Group is initiatin...
09-25 13:32
美股大行评级 | 潜在涨幅208.48%！HC Wainwright & Co.上调Microbot Medical目标价至12美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Microbot Medical"买入"评级，目标价从9美元升至12美元；Maxim Group：维持Neuphoria Therapeutics"买入"评级，目标价从18美元升至35美元
09-12 12:53
Expert Outlook: 10x Genomics Through The Eyes Of 6 Analysts
6 analysts have expressed a variety of opinions on 10x Genomics (NASDAQ:TXG) ov...
09-11 20:01
Piper Sandler Initiates Coverage On 10x Genomics with Neutral Rating, Announces Price Target of $15
Piper Sandler analyst David Westenberg initiates coverage on 10x Genomics (NASDAQ:TXG) with a Neutral rating and announces Price Target of $15.
09-11 19:23
SMG Swiss Marketplace Group Commences IPO Bookbuilding
The latest update is out from TX Group AG ( ($CH:TXGN) ). SMG Swiss Marketplace...
09-11 13:33
